Study offers new insights into why some CAR T-cells persist

New insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell therapy for leukemia have been revealed by researchers at UCL, Great Ormond Street Hospital, and the Wellcome Sanger Institute.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Sam Behjati , Henry Stennett , Sara Ghorashian , Nathaniel Anderson , Danielle Ellis , Wellcome , University College London Hospital , Institute Of Child Health , Jp Moulton , King Health Partners , Research Information , Olivia Hodson Cancer Fund , Wellcome Senior Research , Children Charity , Care Research Biomedical Centres , Wellcome Sanger Institute , Cancer Research United Kingdom , National Institute For Health , Great Ormond Street Hospital , Wellcome Sanger , Nature Medicine , Ormond Street Institute , Child Health , Marie Sklodowska Curie Fellow , Paediatric Haematology , Honorary Senior Clinical Lecturer , Group Lead , Wellcome Senior Research Fellow , Honorary Consultant Paediatric Oncologist , Research Information Manager , Award Scheme , Sklodowska Curie Actions , National Institute , Health Partners , University College London ,